Records containing: Renal Cell Carcinoma (RCC)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23Multimodal PET/MRI Machine Learning Approaches for Characterization of Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-14"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
-
CLINICAL_TRIALS study record update · 2026-04-14Emulated-target Trial for Guiding Stratified Treatment for Renal Cell Carcinoma With Venous Tumor Thrombus
-
CLINICAL_TRIALS study record update · 2026-04-09A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of CTX-10726 in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-08Organ Sparing Marker-less CBCT-guided Stereotactic Adaptive Radiotherapy for Primary Non-metastasized Renal Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-07Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE
-
CLINICAL_TRIALS study record update · 2026-04-01A Phase 3, Randomized, Multi-Center, Open-Label Study to Compare 177Lu-TLX250 (Lutetium (177Lu) Girentuximab Tetraxetan) With the Investigator's Choice of a Single Agent Therapy in Participants With Carbonic Anhydrase 9 (CAIX) Expressing, Advanced Relapsed or Recurrent Clear Cell Renal Cell Carcinoma (ccRCC)
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2026-03-27Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy: a Randomized Controlled Clinical Study
-
CLINICAL_TRIALS study record update · 2026-03-23Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study
-
CLINICAL_TRIALS study record update · 2026-03-12A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination With Immuno-Oncology Agents in Subjects With Unresectable Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-11Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis
-
CLINICAL_TRIALS study record update · 2026-03-05PLUTO: A Prospective Phase II Study of Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy
-
CLINICAL_TRIALS study record update · 2026-02-03Characterizing the Tumor-draining Lymph Nodes and Other Immune Sites in Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2026-01-28Cabozantinib Dose Skipping as an Alternative to Dose Reductions
-
CLINICAL_TRIALS study record update · 2026-01-27A Phase 1b, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics of Sapu003 in Advanced mTOR-sensitive Solid Tumors (With or Without Exemestane)
-
CLINICAL_TRIALS study record update · 2025-12-11A Multicenter, Open-Label, Factorial Design, Randomized Controlled Study to Explore the Efficacy and Safety of Finerenone and Empagliflozin, Alone or in Combination, in Delaying Renal Function Progression in High-Risk CKD Patients After Radical Nephrectomy for Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-11-10A Pilot Study of Blood-Based Biomarkers for Response to Immune Checkpoint Inhibitors
-
CLINICAL_TRIALS study record update · 2025-10-02Clinical Study of CD70-Targeted Chimeric Antigen Receptor T Lymphocytes (CAR-T) in Advanced CD70-Positive Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-09-19CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
-
CLINICAL_TRIALS study record update · 2025-09-16A Study on the Safety and Efficacy of Super-selective Tumour Arterial Embolisation in Combination With Toripalimab and Axitinib as a Preoperative Treatment for Advanced Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-09-16An Open-label, Investigator-initiated, Single Arm, Exploratory Phase 2 Trial Evaluating the Feasibility and Efficiency of PET/CT Directed Free of Therapy Used for Metastatic and Advanced Renal Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-09-16Phase 1-2 Trial of Systemically Administered VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Selected Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-09-15An Open-label, Multicenter, Dose Escalation and Expansion Phase 1/2 Study to Evaluate the Safety, Tolerability and Pharmacokinetics, and Anti-tumor Activity of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as a Single Agent in Patients With Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-09-10A Multicenter, Randomized Controlled Study Comparing Vorolanib Tablets Plus Everolimus With Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed on Immunotherapy Monotherapy or in Combination With TKI